Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$10,411,053
+$2,289,484 QoQ
Shares Held
8,680
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
8.22%
of 13F equity value
Holder Rank
#1,241
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PERKINS CAPITAL MANAGEMENT INC holds $15,153,316 across 7 Drug Manufacturers - General names. LLY ranks #1 (68.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
8,680 | $10,411,053 | |
| 2 | ABBV |
AbbVie Inc.
|
5,307 | $1,335,453 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,500 | $963,750 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,216 | $911,669 | |
| 5 | PFE |
Pfizer Inc
|
33,759 | $812,916 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,180 | $413,711 | |
| 7 | JNJ |
Johnson & Johnson
|
1,200 | $304,764 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,411,053 | 8,680 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $8,121,569 | 8,830 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $9,634,507 | 8,965 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $6,935,670 | 9,090 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,421,125 | 9,520 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $8,089,788 | 9,795 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $7,650,520 | 9,910 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $10,964,393 | 12,376 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $11,427,706 | 12,622 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $9,831,080 | 12,637 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,442,139 | 12,767 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $6,999,878 | 13,032 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $6,115,968 | 13,041 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $4,512,882 | 13,141 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $4,834,941 | 13,216 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $4,273,393 | 13,216 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $4,347,275 | 13,408 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $3,839,648 | 13,408 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,703,557 | 13,408 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,167,233 | 13,708 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $3,146,260 | 13,708 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,560,928 | 13,708 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,314,458 | 13,708 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,066,063 | 13,958 | Shares | Sole | 2020-10-28 | |
| 2020-03-31 | $1,950,125 | 14,058 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||